ID26335A - Metoda untuk mencegah restenosis dengan menggunakan tokotrienol - Google Patents

Metoda untuk mencegah restenosis dengan menggunakan tokotrienol

Info

Publication number
ID26335A
ID26335A IDW20001179A ID20001179A ID26335A ID 26335 A ID26335 A ID 26335A ID W20001179 A IDW20001179 A ID W20001179A ID 20001179 A ID20001179 A ID 20001179A ID 26335 A ID26335 A ID 26335A
Authority
ID
Indonesia
Prior art keywords
tokotrienol
preventing restenosis
restenosis
preventing
Prior art date
Application number
IDW20001179A
Other languages
English (en)
Inventor
Ronald H Lane
F Howard Schneider
Original Assignee
Lipogenic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipogenic Inc filed Critical Lipogenic Inc
Publication of ID26335A publication Critical patent/ID26335A/id

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
IDW20001179A 1997-11-17 1998-11-17 Metoda untuk mencegah restenosis dengan menggunakan tokotrienol ID26335A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US97170397A 1997-11-17 1997-11-17

Publications (1)

Publication Number Publication Date
ID26335A true ID26335A (id) 2000-12-14

Family

ID=25518699

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20001179A ID26335A (id) 1997-11-17 1998-11-17 Metoda untuk mencegah restenosis dengan menggunakan tokotrienol

Country Status (6)

Country Link
EP (1) EP1037628A4 (id)
JP (1) JP2001522880A (id)
AU (1) AU746369B2 (id)
CA (1) CA2310232A1 (id)
ID (1) ID26335A (id)
WO (1) WO1999025336A1 (id)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE470442T1 (de) * 2000-03-31 2010-06-15 Eisai R&D Man Co Ltd Verwendung von gamma-tocotrienol als diuretika
US7713546B1 (en) * 2001-04-03 2010-05-11 Soft Gel Technologies, Inc. Corosolic acid formulation and its application for weight-loss management and blood sugar balance
DE10115740A1 (de) 2001-03-26 2002-10-02 Ulrich Speck Zubereitung für die Restenoseprophylaxe
CA2484383C (en) 2002-07-12 2016-05-31 Cook Incorporated Medical device coated with a bioactive agent
DE10244847A1 (de) 2002-09-20 2004-04-01 Ulrich Prof. Dr. Speck Medizinische Vorrichtung zur Arzneimittelabgabe
US8101199B2 (en) 2003-10-21 2012-01-24 Celonova Biosciences, Inc. Des-methyl-tocopherol therapy for restenosis prevention
EP1811935B1 (en) 2004-09-28 2016-03-30 Atrium Medical Corporation Heat cured gel and method of making
US20060088596A1 (en) 2004-09-28 2006-04-27 Atrium Medical Corporation Solubilizing a drug for use in a coating
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
EP2471530B1 (en) 2005-06-01 2017-01-11 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
AU2006304590A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
JP5374162B2 (ja) 2006-02-22 2013-12-25 エジソン ファーマシューティカルズ, インコーポレイテッド ミトコンドリア病および他の症状の処置のためのレドックス活性化治療の側鎖変異体およびエネルギーバイオマーカーの調節
EP2626091B1 (en) 2006-11-06 2016-09-28 Atrium Medical Corporation Coated surgical mesh
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
US9192697B2 (en) 2007-07-03 2015-11-24 Hemoteq Ag Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
CA2736250C (en) 2008-09-10 2016-12-20 Edison Pharmaceuticals, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
WO2011005421A2 (en) 2009-07-10 2011-01-13 Boston Scientific Scimed, Inc. Use of nanocrystals for a drug delivery balloon
JP5933434B2 (ja) 2009-07-17 2016-06-08 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. 薬剤送達バルーンの製造方法
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
HUE037592T2 (hu) 2009-08-26 2018-09-28 Bioelectron Tech Corp Eljárások cerebrális ischemia megelõzésére és kezelésére
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
US8889211B2 (en) 2010-09-02 2014-11-18 Boston Scientific Scimed, Inc. Coating process for drug delivery balloons using heat-induced rewrap memory
US9056152B2 (en) 2011-08-25 2015-06-16 Boston Scientific Scimed, Inc. Medical device with crystalline drug coating
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
WO2014014517A1 (en) * 2012-07-19 2014-01-23 The Ohio State University Method of ameliorating clotting pathologies and related materials and methods
CN113024369A (zh) 2015-12-17 2021-06-25 Ptc医疗公司 用于治疗氧化应急障碍的化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0543417A1 (en) * 1991-11-22 1993-05-26 Lipogenics, Incorporated Tocotrienols and tocotrienol-like compounds and methods for their use
DE4333794A1 (de) * 1993-10-04 1995-04-06 Carl Heinrich Dr Weischer Neue Acetyl-Salicylsäure-Derivate zur Bekämpfung von Entzündungs- und Schmerzzuständen sowie zur Thromboseprophylaxe und -terapie
EP0669132A1 (en) * 1994-02-23 1995-08-30 van der Kraaij, Antonius Marinus Maria Pharmaceutical composition of vitamin E and acetylsalicylate for treatment and prevention of atherosclerosis

Also Published As

Publication number Publication date
EP1037628A1 (en) 2000-09-27
EP1037628A4 (en) 2002-08-21
JP2001522880A (ja) 2001-11-20
CA2310232A1 (en) 1999-05-27
AU746369B2 (en) 2002-04-18
AU1590299A (en) 1999-06-07
WO1999025336A1 (en) 1999-05-27

Similar Documents

Publication Publication Date Title
ID26335A (id) Metoda untuk mencegah restenosis dengan menggunakan tokotrienol
IS8368A (is) Ný aðferð
FI102426B1 (fi) Menetelmä muistin toteuttamiseksi
DE69830295D1 (de) Steuerungsverfahren
FI102424B1 (fi) Menetelmä muistin toteuttamiseksi
ATE260243T1 (de) N-aroylphenylalaninderivate
EE03801B1 (xx) Stent
FI971620A (fi) Autentikointimenetelmä
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
FI102425B1 (fi) Menetelmä muistin toteuttamiseksi
ID19075A (id) Perangkap tempat kaustik untuk asetaldehida
DE69815975D1 (de) Steuerungsverfahren
IS5106A (is) Ný aðferð
DE69816734D1 (de) Steuerungsverfahren
NO20003079D0 (no) Polymerisasjon-oppstartningsprosess
ATE292632T1 (de) Cis-disubstituierte aminocycloalkyl-pyrrolidin- derivate
DE69708229T2 (de) Muster-Herstellungsverfahren
NO20003080D0 (no) Polymerisasjon-oppstartningsprosess
FI974067A0 (fi) Process foer cellulasbehandling
DE29711942U1 (de) Einrichtung zum Bearbeiten
DE29713277U1 (de) Bohnenstangen-Set
FI102961B (fi) Menetelmä tuhkan käsittelemiseksi
ID21138A (id) Teknologi film-tipis untuk head-drum
FI970906A0 (fi) Säätelymenetelmä
ID19172A (id) Metoda penstabilan